Comparison results
| Results: Differences General | ✘Systemic aspergillosis | ✘Phlebitis | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| systemic aspergillosis | 98% | — | ||||
| purulent thrombophlebitis | — | 76% | ||||
| lung aspergilloma | 61% | — | ||||
| impaired venous function | — | 70% | ||||
| chronic leukemia | 47% | — | ||||
| inflammation | — | 69% | ||||
| acute leukemia | 44% | — | ||||
| pain in the veins | — | 60% | ||||
| immunodeficiency | 44% | — | ||||
| thrombophlebitis | — | 46% | ||||
| chronic granulomatous disease | 38% | — | ||||
| inflammatory infiltrate | — | 44% | ||||
| leukemia | 38% | — | ||||
| reddening of the skin | — | 40% | ||||
| skin cancer | 37% | — | ||||
| vascular damage | — | 37% | ||||
| history of surgery | 35% | — | ||||
| soreness of the skin | — | 36% | ||||
| metastases | 33% | — | ||||
| thrombosis | — | 36% | ||||
| bacteremia | 32% | — | ||||
| onset of illness | — | 33% | ||||
| a history of organ transplantation | 32% | — | ||||
| trauma | — | 32% | ||||
| papules | 31% | — | ||||
| abscess | 32% | 39% | ||||
| cancer | 29% | — | ||||
| sepsis | 32% | 38% | ||||
| impaired lung function | 28% | — | ||||
| skin problems | 27% | 32% | ||||
| blood diseases | 27% | 32% | ||||
Instructions
Video
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.